Comparative evaluation of the effectiveness of balneotherapy and balneotherapy in combination with intravenous laser irradiation of blood at the period of spa treatment of patients with psoriasis
- Authors: Sadovskaya E.A.1, Gorlova N.A.1, Sherengovskaya Y.V.1, Pritulo O.A.1, Prokhorov D.V.1, Ravlyuk D.A.1, Gumenyuk L.N.1
-
Affiliations:
- V.I. Vernadsky Crimean Federal University
- Issue: Vol 100, No 3 (2024)
- Pages: 37-49
- Section: ORIGINAL STUDIES
- URL: https://ogarev-online.ru/0042-4609/article/view/262336
- DOI: https://doi.org/10.25208/vdv1332
- ID: 262336
Cite item
Full Text
Abstract
Background. Psoriasis is one of the most common, chronic, recurrent dermatoses. To date, a sufficient pool of studies has been accumulated confirming the multifactorial genesis of psoriasis due to genetic and environmental factors.
Aim. Сomparative assessment of the effect of different options for spa treatment (ST) balneotherapy and balneotherapy in combination with intravenous laser blood irradiation (ILBI) in patients with psoriasis vulgaris on the level of IL-6 and IL-17, dermatological and psycho-emotional status, assessment of quality of life.
Methods. The comparative study involved 108 patients with psoriasis vulgaris, stationary stage (men — 57.4%, women — 42.6%; the average age was 36.2 [24.5; 47.9] years) who underwent spa treatment, which were subsequently divided into 2 groups: 52 patients who received balneotherapy along with the traditional complex of ST were included in the 1 group, 56 patients who received complex treatment were included in the 2 group. The effectiveness of ST was evaluated using the PASI index, the HARS and HDRS scale, the SF-36 questionnaire. The dynamics of IL-6 and IL-10 levels in blood plasma were evaluated. The total duration of the study was 6 months and 14 days: the treatment phase was 14 days and the follow-up phase was 3 and 6 months after the completion of ST.
Results. After 14 days of ST in the group in which balneotherapy was performed in combination with IVBI, a statistically significant decrease in the PASI index was more pronounced compared to the group in which balneotherapy was performed (p). Balneotherapy did not have a pronounced effect on psychoemotional status. On the contrary, balneotherapy in combination with ILBI contributed to a statistically significant decrease in the final indicators on the HARS and HDRS scales. The decrease in IL-6 and IL-17 levels was statistically significant in both groups and there were no differences between them. The complex use of balneotherapy and ILBI in comparison with the group of balneotherapy was accompanied by a more pronounced improvement in QOL. The combined use of balneotherapy and ILBI in the follow-up phase showed a long-term positive effect: 6 months after the completion of ST, the number of patients who had clinical remission was statistically significantly higher compared to the group in which balneotherapy was performed (87.4 vs. 44.7%).
Conclusion. The advantage of the combined use of balneotherapy and ILBI compared with balneotherapy in patients with psoriasis vulgaris on CL was shown. The complex use of balneotherapy and ILBI of significant indicators of inflammatory biomarkers, improvement of the dermatological and psycho-emotional state, quality of life parameters and good overpopulation. More pronounced effectiveness of the complex use of balneotherapy and ILBI compared to balneotherapy of the quality, diversity of pathophysiological mechanisms of psoriasis and the presence of several targets for pathogenetic therapy.
Full Text
##article.viewOnOriginalSite##About the authors
Ekaterina A. Sadovskaya
V.I. Vernadsky Crimean Federal University
Email: irasad67@mail.ru
ORCID iD: 0000-0002-3614-5063
Student
Russian Federation, SimferopolNina A. Gorlova
V.I. Vernadsky Crimean Federal University
Author for correspondence.
Email: heymakaronka@gmail.com
ORCID iD: 0000-0001-7121-4354
SPIN-code: 1480-1931
Post-Graduate Student
Russian Federation, SimferopolYuliya V. Sherengovskaya
V.I. Vernadsky Crimean Federal University
Email: tkachenko.julia@bk.ru
ORCID iD: 0000-0002-9939-2387
SPIN-code: 3711-3217
Assistant
Russian Federation, SimferopolOlga A. Pritulo
V.I. Vernadsky Crimean Federal University
Email: 55550256@mail.ru
ORCID iD: 0000-0001-6515-1924
SPIN-code: 2988-8463
MD, Dr. Sci. (Med.), Professor
Russian Federation, SimferopolDmitry V. Prokhorov
V.I. Vernadsky Crimean Federal University
Email: dvpro2022@mail.ru
ORCID iD: 0000-0003-2916-8336
SPIN-code: 4365-4376
MD, Dr. Sci. (Med.), Professor
Russian Federation, SimferopolDaria A. Ravlyuk
V.I. Vernadsky Crimean Federal University
Email: darya-ravluk@mail.ru
ORCID iD: 0000-0003-4280-0148
SPIN-code: 5552-2313
MD, Cand. Sci. (Med.), Associate Professor
Russian Federation, SimferopolLesya N. Gumenyuk
V.I. Vernadsky Crimean Federal University
Email: lesya_gymenyuk@mail.ru
ORCID iD: 0000-0003-2785-3882
SPIN-code: 3452-8033
MD, Dr. Sci. (Med.), Professor
Russian Federation, SimferopolReferences
- Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–516. doi: 10.1016/j.jaad.2013.11.013
- Michalek IM, Loring B, John S. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205–212. doi: 10.1111/jdv.13854
- Clark RA. Resident memory T cells in human health and disease. Sci Transl Med. 2015;77(269):269. doi: 10.1126/scitranslmed.3010641
- Хайрутдинов В.Р., Белоусова И.Э., Самцов А.В. Иммунный патогенез псориаза. Вестник дерматологии и венерологии. 2016;4:20–26. [Hajrutdinov VR, Belousova IJe, Samtsov AV. Immune pathogenesis of psoriasis. Vestnik Dermatologii i Venerologii. 2016;4:20–26. (In Russ.)]
- Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-Stoma A, Nockowski P, et al. Cytokines and anticytokines in psoriasis. Clin Chim Acta. 2008;394(1–2):7–21. doi: 10.1016/j.cca.2008.04.005
- Шилова Л.Н., Паньшина Н.Н., Чернов А.С., Трубенко Ю.А., Хортиева С.С., Морозова Т.А., и др. Иммунопатологическое значение интерлейкина-17 при псориатическом артрите. Современные проблемы науки и образования. 2015;6. [Shilova LN, Pan’shina NN, CHernov AS, Trubenko YuA, Hortieva SS, Morozova TA, i dr. Immunopatologicheskoe znachenie interlejkina-17 pri psoriaticheskom artrite. Sovremennye problemy nauki i obrazovaniya, 2015;6. (In Russ.)].
- Фалько Е.В., Хышиктуев Б.С. Нарушения липидного обмена при псориатической болезни. Дальневосточный медицинский журнал. 2009;2:118–122. [Fal’ko EV, Hyshiktuev BS. Metabolic disorders in psoriatic disease. Dal’nevostochnyj medicinskij zhurnal. 2009;2:118–122. (In Russ.)]
- Кушлинский Н.Е., Перламутров Ю.Н., Айвазова Т.В. Особенности ангиогенеза у больных экссудативной формой псориаза. Клиническая дерматология и венерология. 2008;3:8–11. [Kushlinskij NE, Perlamutrov JuN, Ajvazova TV. Osobennosti angiogeneza u bol’nyh jekssudativnoj formoj psoriaza. Klinicheskaja dermatologija i venerologija. 2008;3:8–11. (In Russ.)]
- Бакулев А.Л. Псориаз: клинические особенности, факторы риска и ассоциированные коморбидные состояния. Клиническая фармакология и терапия. 2019;28(1):35–39. [Bakulev A.L. Clinical features of psoriasis, risk factors and associated comorbidity Klinicheskaja farmakologija i terapija. 2019;28(1):35–39. (In Russ.)] doi: 10.32756/0869-5490-2019-1-35-39
- Круглова Л.С., Моисеев С.В. Блокада интерлейкина-17 — новые горизонты эффективности и безопасности в лечении псориаза. Клиническая фармакология и терапия. 2017;26(2):5–12. [Kruglova LS, Moiseev SV. Inhibition of interkeukin-17 — new horizons of efficacy and safety in the treatment of psoriasis. Klinicheskaja farmakologija i terapija. 2017;26(2):5–12. (In Russ.)]
- Куликов А.Г., Шахова А.С. Роль физических факторов в комплексной терапии псориаза. Физиотерапия, бальнеология, реабилитация. 2013;12(1):44–51. [Kulikov AG, Shahova AS. The role of physical factors 44 in the combined treatment of psoriasis (a scientific review). Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2013;12(1):44–51. (In Russ.)] doi: 10.17816/41369
- Kopel E, Levi А, Harari М, Ruzicka T, Ingber A. Effect of the Dead Sea climatotherapy for psoriasis on quality of life. Isr Med Assoc J. 2013;15(2):99–102.
- Донцова Е.В., Новикова Л.А., Бахметьева Т.М., Борзунова Л.Н. Современные подходы к физиотерапии и профилактике псориаза (обзор литературы). Вестник новых медицинских технологий. 2018;2:148–151. [Doncova EV, Novikova LA, Bahmet’eva TM, Borzunova LN. Modern approaches to physiotherapy and prevention of psoriasis (literature review). Journal of New Medical Technologies. 2018;2:148–151. (In Russ.)] doi: 10.24411/2075-4094-2018-16023
- Péter I, Jagicza A, Ajtay Z, Boncz I, Kiss I, Szendi K, et al. Balneotherapy in Psoriasis Rehabilitation. In Vivo. 2017;31(6):1163–1168. doi: 10.21873/invivo.11184
- Zoran G, Marina J, Biljana J, Siniša J. Balneotherapy of Psoriasis. Serbian Journal of Dermatology and Venereology. 2014;6(3):105–112. doi: 10.2478/sjdv-2014-0009
- Matz H, Orion E, Wolf R. Balneotherapy in dermatology. Dermatol Ther. 2003;16(2):132–140. doi: 10.1046/j.1529-8019.2003.01622.x
- Riyaz N, Arakkal FR. Spa therapy in dermatology. Indian J Dermatol Venereol Leprol. 2011;77(2):128–134. doi: 10.4103/0378-6323.77450
- Колоколов А.П., Громова А.В., Самотейкина Л.В. Физиотерапевтическая больница «Черные воды»: история, современное состояние, перспективы развития. Вестник физиотерапии и курортологии. 2013;16(4):67–69. [Kolokolov AP, Gromova AV, Samotejkina LV. Fizioterapevticheskaja bol’nica “Chernye vody”: istorija, sovremennoe sostojanie, perspektivy razvitija. Vestnik fizioterapii i kurortologii. 2013;16(4):67–69. (In Russ.)]
- Поберская В.А. Состояние и перспективы развития бальнеогрязелечения на курортах Крыма. Физиотерапия, бальнеология и реабилитация. 2016;15(5):264–265. [Poberskaja VA. Sostojanie i perspektivy razvitija bal’neogrjazelechenija na kurortah Kryma. Fizioterapija, bal’neologija i reabilitacija. 2016;15(5):264–265. (In Russ.)]
- Нгема М.В., Винцерская Г.А., Кузнецова М.Ю., Шеренговская Ю.В., Прохоров Д.В., Тарасова Е.С. Эффективность использования лечебных факторов местного бальнеологического курорта «Черные воды» (Крым) в этапной терапии больных псориазом. Таврический медико-биологический вестник. 2018;21(2):65–69. [Ngema MV, Vincerskaja GA, Kuznecova MJu, Sherengovskaya YV, Prokhorov DV, Tarasova ES. Efficiency of using therapeutic factors of the local balneological resort “The Black Water” (Crimea) in stage therapy of patients with psoriasis. Tavricheskij mediko-biologicheskij vestnik. 2018;21(2):65–69. (In Russ.)]
- Москвин С.В., Утц С.Р., Шнайдер Д.А. Комбинированная лазерная терапия больных псориазом, включающая внутривенное лазерное освечивание крови и местное воздействие на очаги. Лазерная медицина. 2015;19(4):44–48. [Moskvin SV, Utz SR, Shnaider DA. Combined laser therapy of patients with psoriasis including intravenous laser blood irradiation and topical irradiation of lesions. Laser Medicine. 2015;19(4):44–48. (In Russ.)] doi: 10.37895/2071-8004-2015-19-4-44-48
- Москвин С.В., Утц С.Р., Шнайдер Д.А Комбинированная лазерная терапия больных псориазом. Вестник новых медицинских технологий. 2015;22(4):99–103. [Moskvin SV, Utsh SR, Shnaider DA. The combined laser therapy in patients with psoriasis. Journal of New Medical Technologies. 2015;22(4):99–103. (In Russ.)] doi: 10.12737/17032
- Исмаилов Е.Л., Кокуров А.Л., Саулеева Ж.К. Применение внутрисосудистого лазерного облучения крови у больных с гипертонической болезнью. Вестник Казахского национального медицинского университета. 2016;1:319–321. [Ismailov EL, Kokurov AL, Sauleeva GK. The use of intravascular laser irradiation of blood in patients with hypertension. Bulletin of the Kazakh National Medical University. 2016;1:319–321. (In Russ.)]
- Шахова А.С., Куликов А.Г., Герцен А.В., Миннибаев М.Т., Корсунская И.М., Игнатова И.В., и др. Сравнительный анализ эффективности низкоинтенсивного лазерного излучения и ПУВА-терапии в лечении псориаза. Физиотерапия, бальнеология, реабилитация. 2010;9(4):16–21. [Shakhova AS, Kulikov AG, Herzen AV, Minibaev MT, Korsunskaya IM, Ignatova IV, et al. Comparative analysis of the efficiency of low-intensity laser irradiation and PUVA therapy for the treatment of psoriasis. Russian journal of physiotherapy, balneology and rehabilitation. 2010;9(4):16–21. (In Russ.)] doi: 10.17816/41095
- Зырянов Б.Н., Евтушенко В.А., Кицманюк З.Д. Низкоинтенсивная лазерная терапия в онкологии. Томск: STT; 1998. 336 с. [Zyrjanov BN, Evtushenko VA, Kicmanjuk ZD. Nizkointensivnaja lazernaja terapija v onkologii. Tomsk: STT; 1998. 336 s. (In Russ.)]
- Moon HS, Mizara А, McBride SR. Psoriasis and psycho-dermatology. Dermatol Ther (Heidelb). 2013;3(2):117–130. doi: 10.1007/s13555-013-0031-0
- Дегтяренко С.А. О пользе йодобромных ванн. Главный врач Юга России. 2016;1(48):39–41. [Degtjarenko SA. O pol’ze jodobromnyh vann. Glavnyj vrach Juga Rossii. 2016;1(48):39–41. (In Russ.)]
- Смолиенко В.Н., Нгема М.В., Кузнецова М.Ю. Эффективность использования бальнеотерапии при лечении больных венозными трофическими язвами при варикозной экземе. Вестник физиотерапии и курортологии. 2016;3:77–78. [Smolienko VN, Ngema MV, Kuznecova MJu. Jeffektivnost’ ispol’zovanija bal’neoterapii pri lechenii bol’nyh venoznymi troficheskimi jazvami pri varikoznoj jekzeme. Vestnik fizioterapii i kurortologii. 2016;3:77–78. (In Russ.)]
- Castex-Rizzi N, Charveron M, Merial-Kieny C. Inhibition of TNF-alpha induced-adhesion molecules by Avene Th ermal Spring Water in human endothelial cells. J Eur Acad Dermatol Venereol. 2011;25(1):6–11. doi: 10.1111/j.1468-3083.2010.03893.x
- Basavaraj KH, Darshan MS, Shanmugavelu P, Rashmi R, Mhatre AY, Dhanabal SP, et al. Study on the levels of trace elements in mild and severe psoriasis. Clin Chim Acta. 2009;405(1–2):66–70. doi: 10.1016/j.cca.2009.04.012
- Boros M, Kemeny A, Sebők B, Bagoly T, Perkecz A, Petőházi Z, et al. Sulphurous medicinal waters increase somatostatin release: it is a possible mechanism of anti-infl ammatory effect of balneotherapy in psoriasis. European Journal of Integrative Medicine. 2013;5(2):109–118. doi: 10.1016/j.eujim.2012.09.005
- Moynihan J, Rieder E, Tausk F. Psychoneuroimmunology: the example of psoriasis. G Ital Dermatol Venereol. 2010;145(2):221–228.
- Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol. 2002;16(4):347–352. doi: 10.1046/j.1468-3083.2002.00467.x
- Nestle FO. Psoriasis. Curr Dir Autoimmun 2008;10:65–75. doi: 10.1159/000131424
- Yasumoto S, Imayama S, Hori Y. Increased serum level of interleukine-6 in patients with psoriatic arthritis and thrombocytosis. J Dermatol. 1995;22(10):718–722. doi: 10.1111/j.1346-8138.1995.tb03908.x
- Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol. 2010;35(6):645–649. doi: 10.1111/j.1365-2230.2009.03704.x
- Yamada H. Current perspectives on the role of IL-17 in autoimmune disease. J Inflam Res. 2010;3:33–44. doi: 10.2147/jir.s6375
- Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, at al. Italian guidelines on the systemic trea-tments of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2017;31(5):774–790. doi: 10.1111/jdv.14114
Supplementary files
